Publication | Open Access
Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain
54
Citations
28
References
2013
Year
suPAR is a strong predictor of adverse long-term outcomes and improves risk stratification beyond traditional risk variables in chest pain patients admitted with suspected NSTEACS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1